Week in Review
President Biden issues an executive order on reproductive health care, declares monkeypox a public health emergency, and more…
Detoxifying Social Media
Expert urges regulators to change incentives for social media to create a healthier digital sphere.
The Unintended Consequences of Self-Harm Monitoring Software
Experts call for policies to govern self-harm monitoring technology employed by schools.
Turning a Corner on a Rocky History with ESG
Scholars argue that the SEC has historically resisted creating ESG disclosures but has recently changed course.
How Regulators Should Supervise Software
The CFTC and other regulators should evaluate with caution proposals to automate financial transactions.
Reforming Accountable Care Organizations
Experts explore opportunities to reduce costs and promote health equity.
Week in Review
HHS proposes rule to strengthen LGBTQ+ protections under ACA, Education Department proposes accountability measures for for-profit colleges, and more . . .
Cancer Moonshot Lands with FDA
FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.
With Proposed Menthol Cigarette Rule, FDA Says Cool It
FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.
The No Surprises Act Still Surprises Consumers
Medical bills may continue to take consumers by surprise despite the No Surprises Act.
Do Not Blame Us
Court disregards the Clean Air Act’s clear language in applying the major questions doctrine to curb EPA’s climate authority.
Making Regulations on Influencer Advertising Click
Scholars offer approaches to improve regulation of social media marketing.